The objective of the current investigation is to reduce dosing frequency and improve patient compliance by designing and systematically evaluating mucoadhesive microspheres of Valsartan. Frequent administration and variable low bioavailability (20-25%) after oral administration are problems of conventional dosage forms of valsartan can be attenuated by designing it in the form of mucoadhesive microspheres which would prolong the residence time at the absorption site to facilitate intimate contact with the absorption surface and thereby improve and enhance the bioavailability. Valsartan microspheres were formulated by emulsification solvent-evaporation technique using HPMC K100, Ethyl cellulose as a mucoadhesive polymer with 80.60% entrapment efficiency. The scanning electron microscopic study indicated that the microspheres were spherical in shape and the drug remained dispersed in the polymer matrix at amorphous state, which was further confirmed by X-ray diffraction analysis. The in-vitro wash-off test indicated that the microspheres had good mucoadhesive properties. The wash-off was faster at simulated intestinal fluid (phosphate buffer, pH 7.4) than that at simulated gastric fluid (0.1 M HCl, pH 1.2). The in-vitro drug release mechanism was non-fickian type controlled by swelling and relaxation of polymer. There was no significant change in drug content and cumulative drug release of drug-loaded microspheres stored at different storage condition after 9 weeks of study.
Loading....